Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial

Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial. Dickinson, Laura; Gurjar, Rohan; Stöhr, Wolfgang; Bonora, Stefano; Owen, Andrew; D'Avolio, Antonio; Cursley, Adam; Molina, Jean-Michel; Fäetkenheuer, Gerd; Vandekerckhove, Linos; Di Perri, Giovanni; Pozniak, Anton; Richert, Laura; Raffi, François; Boffito, Marta; NEAT001/ANRS143 Study Group. The Journal of Antimicrobial Chemotherapy. 2020; 75: p.628-639. doi:10.1093/jac/dkz479
Article